D. Girawan, “Immune Checkpoint Inhibitors (ICIs) on Patients With Hepatitis B Virus Infection: A Promising Approach for Achieving HBsAg Loss”, InaJGHE, vol. 27, no. 1, pp. 1–2, Apr. 2026.